Zealand Pharma A/S leads structurally, with profitability as the clearest single gap between the two profiles. ONEOK still has the edge on growth, which keeps the comparison from looking entirely one-sided. In the market, ONEOK carries the stronger setup — intact trend against Zealand Pharma A/S's broken trend. That leaves a split case: the structural lead stays with Zealand Pharma A/S, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (OKE: S&P 500, ZEAL.CO: STOXX 600).
The comparison is mainly decided in profitability, with the rest of the profile carrying less weight. The overall score gap is 17 points in favour of Zealand Pharma A/S.
This pair is matched through long-term financial trajectory similarity within the selected peer universe.
The pair shares a valid long-term profile match, but the trajectories are not especially close.
The strongest overlap appears in capital structure.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Score differences across key dimensions.
Left means cheaper relative valuation. Higher means stronger structure.
Zealand Pharma A/S still looks stronger, and the price setup does not materially undermine that lead.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where OKE and ZEAL.CO each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The profitability lead is mainly driven by a 73-point operating margin advantage.
ONEOK still pushes back on growth by a very wide margin, which keeps the read from becoming one-way.
Profitability settles the main question, even though growth still keeps the broader picture from looking fully clean.
Break down the OKE vs ZEAL.CO comparison across all dimensions with the full interactive tool.
Explore how OKE and ZEAL.CO each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.